Form 4: CONMED Director Reports Stock Transaction
Insider Transaction (Form 4)
Kim Kelderman, a Director of CONMED Corp, reported multiple transactions in common stock on September 8, 2026.
Summary
- Option exercise/conversion: acquired 500 Common Stock on September 8, 2026; holds 500 after (Direct).
- Option exercise/conversion: disposed of 500 RSUs (Restricted Stock Units) on September 8, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Kim Kelderman — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Option exercise/conversion | Common Stock | 500 | — | — | 500 |
| 2026-09-08 | Option exercise/conversion | RSUs (Restricted Stock Units) | 500 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Option exercise/conversion (500 shares) |
| 2026-09-08 | Option exercise/conversion (500 shares) |
Keywords
insider transaction, Form 4, CNMD, CONMED Corp, neutral, Kim Kelderman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.